Login / Signup
Financial toxicity from newly approved second-/third-line agents in metastatic urothelial carcinoma.
David J Benjamin
Mark P Lythgoe
Arash Rezazadeh
Published in:
BJU international (2023)
Keyphrases
</>
squamous cell carcinoma
small cell lung cancer
drug administration
oxidative stress
affordable care act
healthcare